Vaughan Nelson Investment Management L.P. Has $2.16 Million Stock Holdings in CVS Health Co. (NYSE:CVS)

Vaughan Nelson Investment Management L.P. increased its position in shares of CVS Health Co. (NYSE:CVS) by 16.8% during the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 34,285 shares of the pharmacy operator’s stock after acquiring an additional 4,920 shares during the quarter. Vaughan Nelson Investment Management L.P.’s holdings in CVS Health were worth $2,156,000 at the end of the most recent quarter.

Other large investors have also made changes to their positions in the company. Livelsberger Financial Advisory acquired a new position in shares of CVS Health during the third quarter valued at $31,000. Reston Wealth Management LLC bought a new stake in CVS Health in the third quarter valued at about $32,000. First Community Trust NA increased its holdings in CVS Health by 116.2% in the second quarter. First Community Trust NA now owns 562 shares of the pharmacy operator’s stock valued at $33,000 after purchasing an additional 302 shares during the last quarter. Kathleen S. Wright Associates Inc. bought a new stake in CVS Health in the third quarter valued at about $33,000. Finally, ORG Partners LLC increased its holdings in CVS Health by 11,840.0% in the second quarter. ORG Partners LLC now owns 597 shares of the pharmacy operator’s stock valued at $35,000 after purchasing an additional 592 shares during the last quarter. Institutional investors and hedge funds own 80.66% of the company’s stock.

CVS Health Trading Down 3.4 %

Shares of CVS Health stock opened at $53.19 on Monday. The business has a fifty day simple moving average of $59.23 and a two-hundred day simple moving average of $58.60. CVS Health Co. has a 1 year low of $52.71 and a 1 year high of $83.25. The company has a market capitalization of $66.93 billion, a price-to-earnings ratio of 13.50, a P/E/G ratio of 0.92 and a beta of 0.55. The company has a debt-to-equity ratio of 0.80, a current ratio of 0.80 and a quick ratio of 0.59.

CVS Health (NYSE:CVS) last announced its quarterly earnings results on Wednesday, November 6th. The pharmacy operator reported $1.09 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.08 by $0.01. The business had revenue of $95.43 billion during the quarter, compared to the consensus estimate of $92.72 billion. CVS Health had a return on equity of 10.72% and a net margin of 1.36%. The company’s quarterly revenue was up 6.3% on a year-over-year basis. During the same quarter last year, the firm posted $2.21 EPS. Research analysts forecast that CVS Health Co. will post 5.48 EPS for the current year.

CVS Health Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, November 1st. Shareholders of record on Monday, October 21st were given a dividend of $0.665 per share. This represents a $2.66 annualized dividend and a yield of 5.00%. The ex-dividend date was Monday, October 21st. CVS Health’s payout ratio is 67.51%.

Wall Street Analyst Weigh In

A number of equities research analysts recently commented on CVS shares. Royal Bank of Canada dropped their price objective on CVS Health from $68.00 to $58.00 and set an “outperform” rating for the company in a report on Friday. Wells Fargo & Company lowered their price target on CVS Health from $61.00 to $60.00 and set an “equal weight” rating for the company in a report on Monday, November 4th. Barclays lowered their price target on CVS Health from $75.00 to $71.00 and set an “overweight” rating for the company in a report on Thursday, November 7th. Mizuho lowered their price target on CVS Health from $73.00 to $66.00 and set an “outperform” rating for the company in a report on Thursday, October 24th. Finally, Deutsche Bank Aktiengesellschaft lowered their price target on CVS Health from $64.00 to $63.00 and set a “hold” rating for the company in a report on Friday, August 9th. One investment analyst has rated the stock with a sell rating, eight have assigned a hold rating and twelve have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $72.44.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.